GeoVax Labs Inc. (GOVX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

GeoVax Labs Inc. (GOVX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

2.10

-0.02 (-0.94%)

At close: Jan 14, 2025, 3:59 PM

2.12

0.71%

Pre-market Jan 15, 2025, 06:35 AM EST

undefined% (undefined)

Bid	2.01
Market Cap	19.86M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-8.39
PE Ratio (ttm)	-0.25
Forward PE	n/a
Analyst	Buy

Ask	2.18
Volume	271,845
Avg. Volume (20D)	1,713,175
Open	2.15
Previous Close	2.12
Day's Range	2.08 - 2.23
52-Week Range	1.09 - 11.18
Beta	undefined

About GOVX

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, ch...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Sep 25, 2020

Employees 17

Stock Exchange NASDAQ

Ticker Symbol GOVX

Website https://www.geovax.com

Analyst Forecast

According to 6 analyst ratings, the average rating for GOVX stock is "Buy." The 12-month stock price forecast is $16.5, which is an increase of 683.85% from the latest price.

Buy 83.33%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

GeoVax Labs Inc. is scheduled to release its earnings on Feb 27, 2025, during market hours.
Analysts project revenue of $920.00K, reflecting a n/a YoY growth and earnings per share of -0.95, making a -75.89% decrease YoY.

Why Price Moved

2 months ago · Source

-16.92%

GeoVax Labs shares are trading lower. The company ... Unlock content with Pro Subscription

2 months ago · Source

+3.5%

GeoVax Labs shares are trading lower. The company reported Q3 financial results.

News

1 month ago · marketbeat.com

3 Penny Stocks Ready to Break Out in 2025

Known for their uncommonly pronounced risk/reward profile, penny stocks all too often entice investors with their low prices and potential for significant returns, only to fail to live up to those exp...

2 months ago · seekingalpha.com

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript